MONTREAL, Feb. 26 /CNW Telbec/ - The Fédération des chambres de commerce
du Québec (FCCQ) announced today the selection of Ranaz Corporation
(TSX-V: RNZ) as a finalist of the coveted Mercuriades 2008 business awards
competition in the Retail and Distribution category. Ranaz earned this
selection as a result of the distribution success of its ProtiLife brand of
weight-loss products. Nine months after its launch, these products are now
available in over 4,000 Canadian sales outlets. Ranaz is a company
specializing in the manufacturing and marketing of protein and dietary
supplements. "This award is a great achievement for us," says Jean
Bourassa-Marineau, President and CEO of Ranaz. "We are very proud of the
progress accomplished in the past year, which has seen our corporation grow
from a private company to a publicly listed corporation. We are particularly
grateful to our customers, made up of retail pharmacy chains, supermarkets and
mass merchandisers across the country, for the confidence bestowed upon us
which has allowed us to rapidly establish a strong presence."
About the Mercuriades
Organized by the Fédération des chambres de commerce du Québec (FCCQ),
the Mercuriades is Québec's most popular and prestigious competition dedicated
to recognizing businesses that demonstrate exceptional performance,
entrepreneurship, and excellence.
About Ranaz Corporation
Ranaz is a corporation specializing in the manufacture and marketing of
protein and dietary supplements. Its mission is to design, develop and market
nutritional, protein and dietary supplements under its own corporate brands,
such as Protidiet and ProtiLife, as well as under private labels.
ProtiLife Brand Products
The ProtiLife brand enables Ranaz to capitalize on its experience in
developing weight-loss and obesity treatment products by introducing a
mass-market product supported by scientific research. The Corporation wishes
to position this brand to eventually establish itself as a world-class leader
in the development and marketing of quality and effective high-protein weight
loss and health supplements, and for its consumer market expertise.
Certain statements contained in this news release, other than statements
of fact that are independently verifiable at the date hereof, may constitute
forward-looking statements. Such statements, based as they are on the current
expectations of management, inherently involve numerous risks and
uncertainties, known and unknown, many of which are beyond Ranaz's control.
Such risks include but are not limited to: the impact of general economic
conditions, changes in the regulatory environment in the jurisdictions in
which Ranaz does business, stock markets volatility, fluctuations in costs,
and changes to the competitive environment due to consolidation, as well as
other risks disclosed in public filings of Ranaz. Consequently, actual future
results may differ materially from the anticipated results expressed in the
forward-looking statements. The reader should not place undue reliance, if
any, on the forward-looking statements included in this news release. These
statements speak only as of the date made and Ranaz is under no obligation and
disavows any intention to update or revise such statements as a result of any
event, circumstances or otherwise.
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.
For further information:
For further information: Ranaz Corporation: Martin Vidal, Executive Vice
President and Chief Financial Officer, (450) 491-7106, ext. 213,
email@example.com; Impact Communication: Carlo Tarini, (514)